Delivery Order SPE2DB22D2006-SPE2DB24FW2ST
Award Date
8/7/24
Potential Completion Date
8/8/24
Potential Value
$27K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Insulin Aspart 100 Unit/mL Vials (10 mL) to the Defense Logistics Agency (DLA). The contract, valued at $2,250.10, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 22, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award is for the delivery of 10 milliliter vials of insulin aspart 100 unit/milliliter. The award, with a ceiling value of $1,738.30, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order and has a firm fixed price pricing type, with a period of performance extending to July 10, 2023. The contract was not set aside for any specific type of business. AmerisourceBergen holds a...
This federal contract award, valued at $2,603.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4564943786 - Insulin Aspart 100 Unit/mL in 10mL vials, with a completion date of June 20, 2024. This award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,171.57 firm-fixed-price delivery order is for the supply of Insulin Aspart 100 Unit/mL Vial, 10mL. The contract has an ultimate completion date of August 23, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of 10 ml vials of Insulin Aspart 100 Unit/ml. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract has a ceiling value of $7,692.48 and is a firm fixed price delivery order. This award appears to be part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to...
This federal contract award is for the delivery of Insulin Aspart 100 Unit/mL Pen 3mL, a critical pharmaceutical product, to the U.S. government. The $14,535.08 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of September 9, 2024. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,641.34, is for the delivery of 4564186129 Insulin Aspart 100 Unit/mL Vial 10mL. The contract has a firm fixed price and an ultimate completion date of April 8, 2024. The contract is a delivery order and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a...
The Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $2,271.15 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Insulin Aspart 100 Unit/mL vials. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a...
This federal contract award is for the delivery of insulin aspart 100 unit/ml vials, with a ceiling value of $1,316.60. The contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract type is a delivery order, with a firm fixed price pricing arrangement, and an ultimate completion date of December 31, 2024. This award is not associated with any set-aside designation, indicating...
This federal contract award is for the delivery of Insulin Aspart 100 Unit/ML Pen 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $8,765.68, was granted to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of February 1, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...